These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8393859

  • 1. Nerve growth factor-gamma activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB, Vasudevan J, Henkin J, Gonias SL.
    J Biol Chem; 1993 Aug 05; 268(22):16327-31. PubMed ID: 8393859
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor-binding protein activates soluble and receptor-bound single chain urokinase-type plasminogen activator.
    Wolf BB, Brown MD.
    FEBS Lett; 1995 Dec 04; 376(3):177-80. PubMed ID: 7498536
    [Abstract] [Full Text] [Related]

  • 3. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F, Van Hoef B, Bini A, Collen D, Lijnen HR.
    Biochemistry; 1998 May 19; 37(20):7231-6. PubMed ID: 9585535
    [Abstract] [Full Text] [Related]

  • 4. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
    Barnathan ES, Kuo A, Rosenfeld L, Karikó K, Leski M, Robbiati F, Nolli ML, Henkin J, Cines DB.
    J Biol Chem; 1990 Feb 15; 265(5):2865-72. PubMed ID: 2154462
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
    Fleury V, Lijnen HR, Anglés-Cano E.
    J Biol Chem; 1993 Sep 05; 268(25):18554-9. PubMed ID: 8103046
    [Abstract] [Full Text] [Related]

  • 6. Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.
    Schwartz BS.
    J Biol Chem; 1994 Mar 18; 269(11):8319-23. PubMed ID: 7907591
    [Abstract] [Full Text] [Related]

  • 7. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    Eur J Biochem; 1988 Nov 15; 177(3):575-82. PubMed ID: 2973984
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L, Lijnen HR, Collen D, Holmes WE.
    J Biol Chem; 1987 Aug 05; 262(22):10855-62. PubMed ID: 2956260
    [Abstract] [Full Text] [Related]

  • 9. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
    Lijnen HR, Van Hoef B, Collen D.
    Eur J Biochem; 1987 Dec 01; 169(2):359-64. PubMed ID: 2961562
    [Abstract] [Full Text] [Related]

  • 10. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase).
    Stack MS, Johnson DA.
    J Biol Chem; 1994 Apr 01; 269(13):9416-9. PubMed ID: 8144524
    [Abstract] [Full Text] [Related]

  • 11. Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C).
    Nauland U, Rijken DC.
    Eur J Biochem; 1994 Jul 15; 223(2):497-501. PubMed ID: 8055919
    [Abstract] [Full Text] [Related]

  • 12. Comparative kinetic analysis of the activation of human plasminogen by natural and recombinant single-chain urokinase-type plasminogen activator.
    Lijnen HR, Van Hoef B, Collen D.
    Biochim Biophys Acta; 1986 Dec 10; 884(3):402-8. PubMed ID: 3778931
    [Abstract] [Full Text] [Related]

  • 13. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.
    Braat EA, Collen A, Jie AF, Grimbergen JM, Rijken DC.
    Biochim Biophys Acta; 2000 Sep 20; 1497(3):351-8. PubMed ID: 10996659
    [Abstract] [Full Text] [Related]

  • 14. Characterization of plasminogen activation by glycosylphosphatidylinositol-anchored urokinase.
    Lee SW, Ellis V, Dichek DA.
    J Biol Chem; 1994 Jan 28; 269(4):2411-8. PubMed ID: 8300567
    [Abstract] [Full Text] [Related]

  • 15. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
    Berkenpas MB, Quigley JP.
    Proc Natl Acad Sci U S A; 1991 Sep 01; 88(17):7768-72. PubMed ID: 1652763
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME, Rijken DC, Groeneveld E, van Berkel TJ, Kuiper J.
    Thromb Haemost; 1995 Aug 01; 74(2):722-9. PubMed ID: 8585013
    [Abstract] [Full Text] [Related]

  • 18. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
    Stump DC, Lijnen HR, Collen D.
    J Biol Chem; 1986 Dec 25; 261(36):17120-6. PubMed ID: 3097021
    [Abstract] [Full Text] [Related]

  • 19. Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.
    Booyse FM, Lin PH, Traylor M, Bruce R.
    J Biol Chem; 1988 Oct 15; 263(29):15139-45. PubMed ID: 3170576
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR, Nelles L, Van Hoef B, Demarsin E, Collen D.
    J Biol Chem; 1988 Dec 15; 263(35):19083-91. PubMed ID: 3143723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.